home / stock / nspr / nspr news

NSPR News and Press, InspireMD Inc. From 10/13/21

Stock Information
Company Name: InspireMD Inc.
Stock Symbol: NSPR
Market: NASDAQ
Website: inspiremd.com
Menu
NSPR NSPR Quote NSPR Short NSPR News NSPR Articles NSPR Message Board
Get NSPR Alerts

News, Short Squeeze, Breakout and More Instantly...
NSPR - InspireMD Receives Reimbursement Approval for CGuard(TM) Embolic Prevention System from the French National Authority for Health

TEL AVIV, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard EPS stent system...
NSPR - Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices

Palm Beach, FL – September 21, 2021 – FinancialNewsMedia.com News Commentary Growing prevalence of cardiovascular disorders (CVDs) globally is anticipated to substantially increase in the upcoming years. Hypertension, smoking, alcohol consumption, and consumption o...

NSPR - InspireMD: Revolutionizing The Field Of Vascular Stenting

InspireMD develops and commercializes proprietary stent designs with a proprietary mesh. The Company seeks to change the SoC in the treatment of CAD and other invasive indications utilizing an integrated embolic protection stent platform. The Company’s commercialized produc...

NSPR - NeuroMetrix, Reneo Pharmaceuticals leads healthcare gainers; Cassava Sciences, Applied Therapeutics among major losers

Gainers: NeuroMetrix (NASDAQ:NURO) +54%, Reneo Pharmaceuticals (NASDAQ:RPHM) +24%, Neoleukin Therapeutics (NASDAQ:NLTX) +21%, Chembio Diagnostics (NASDAQ:CEMI) +17%, InspireMD (NASDAQ:NSPR) +14%. Losers: Cassava Sciences (NASDAQ:SAVA) -28%, Applied Ther...
NSPR - InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q2 2021 Results - Earnings Call Transcript

Start Time: 8:30 End Time: 08:51 InspireMD, Inc. (NSPR) Q2 2021 Earnings Conference Call August 10, 2021, 08:30 AM ET Company Participants Marvin Slosman - CEO Craig Shore - CFO Jules Abraham - CORE IR Conference Call Participants Benjamin Haynor - Alliance Global Partners Presentation Operat...

NSPR - InspireMD, Inc. 2021 Q2 - Results - Earnings Call Presentation

The following slide deck was published by InspireMD, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: InspireMD, Inc. 2021 Q2 - Results - Earnings Call Presentation

NSPR - InspireMD Announces Strong Second Quarter 2021 Financial Results

Revenue rebound, strong procedural recovery Management to host investor conference call today, August 10, 2021, at 8:30am ET TEL AVIV, Israel, Aug. 10, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prev...
NSPR - InspireMD to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021, and Provide Corporate Update

TEL AVIV, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces it will report fiscal first quarter 2021 ...

NSPR - InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

TEL AVIV, Israel, July 23, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successf...

NSPR - NSPR, SPRT, KLDO among mid-day movers

Gainers: ImmunoPrecise Antibodies (IPA) +157%.India Globalization Capital (IGC) +74%.NRx Pharmaceuticals (NRXP) +56%.Universe Pharmaceuticals (UPC) +30%.Summit Wireless Technologies (WISA) +28%.Support.com (SPRT) +25%.Agrify Corporation (AGFY) +20%.PainReform (PRFX) +19%.Resources Connec...
Previous 10 Next 10